...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR 2020 Poster

Bear iti looks like what we have seen.Anything new?From My perspective it looks like Zen has a positive future.

Share
New Message
Please login to post a reply